Who Owns CVKD?

Cadrenal Therapeutics, Inc. Common Stock — Institutional Ownership & 13F Holdings

$5.26

-0.44 (-7.72%)

Market Cap

$18.7M

Shares Outstanding

2,506,817

Institutional Holders

16

Total Inst. Value

$1.2M

% of Float Held

QoQ Holder Change

+6

Institutional data as of Q1 2025

New Positions

11

Closed Positions

2

Increased

3

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INCNew$804K45,633
2GEODE CAPITAL MANAGEMENT, LLC$212K12,086
3UBS Group AG$149K8,445
4OSAIC HOLDINGS, INC.New$26K1,500
5MORGAN STANLEY$19K1,130
6JONES FINANCIAL COMPANIES LLLPNew$4K140
7WELLS FARGO & COMPANY/MNNew$2K100
8JPMORGAN CHASE & CONew$1K100
9Archer Investment CorpNew$61735
10IFP Advisors, IncNew$52930

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-16$19K

Related Stocks

Frequently Asked Questions

How many institutional investors hold CVKD?

As of Q1 2025, 16 institutional investors report holding CVKD (Cadrenal Therapeutics, Inc. Common Stock) in their 13F filings.

Which hedge fund owns the most CVKD?

The largest institutional holder of CVKD is VANGUARD GROUP INC with $804K in shares.

Are institutions buying or selling CVKD?

This quarter, 11 institutions opened new positions in CVKD and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.